As of 2024-12-13, the EV/EBITDA ratio of Merck & Co Inc (MRK) is 9.58. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Merck's latest enterprise value is 279,664.06 mil USD. Merck's TTM EBITDA according to its financial statements is 29,203.00 mil USD. Dividing these 2 quantities gives us the above Merck EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 7.7x - 10.0x | 8.7x |
| Forward P/E multiples | 19.1x - 26.0x | 20.5x |
| Fair Price | 52.87 - 105.68 | 74.27 |
| Upside | -47.8% - 4.4% | -26.6% |
| Date | EV/EBITDA |
| 2024-12-12 | 9.58 |
| 2024-12-11 | 9.45 |
| 2024-12-10 | 9.55 |
| 2024-12-09 | 9.80 |
| 2024-12-06 | 9.74 |
| 2024-12-05 | 9.78 |
| 2024-12-04 | 9.59 |
| 2024-12-03 | 9.63 |
| 2024-12-02 | 9.52 |
| 2024-11-29 | 9.61 |
| 2024-11-27 | 9.74 |
| 2024-11-26 | 9.61 |
| 2024-11-25 | 9.57 |
| 2024-11-22 | 9.40 |
| 2024-11-21 | 9.46 |
| 2024-11-20 | 9.25 |
| 2024-11-19 | 9.17 |
| 2024-11-18 | 9.17 |
| 2024-11-15 | 9.15 |
| 2024-11-14 | 9.33 |
| 2024-11-13 | 9.34 |
| 2024-11-12 | 9.35 |
| 2024-11-11 | 9.53 |
| 2024-11-08 | 9.72 |
| 2024-11-07 | 9.57 |
| 2024-11-06 | 9.53 |
| 2024-11-05 | 9.61 |
| 2024-11-04 | 9.63 |
| 2024-11-01 | 9.63 |
| 2024-10-31 | 9.67 |
| 2024-10-30 | 9.89 |
| 2024-10-29 | 9.79 |
| 2024-10-28 | 9.83 |
| 2024-10-25 | 9.81 |
| 2024-10-24 | 9.98 |
| 2024-10-23 | 10.02 |
| 2024-10-22 | 10.04 |
| 2024-10-21 | 10.02 |
| 2024-10-18 | 10.22 |
| 2024-10-17 | 10.31 |
| 2024-10-16 | 10.37 |
| 2024-10-15 | 10.47 |
| 2024-10-14 | 10.31 |
| 2024-10-11 | 10.31 |
| 2024-10-10 | 10.28 |
| 2024-10-09 | 10.36 |
| 2024-10-08 | 10.21 |
| 2024-10-07 | 10.21 |
| 2024-10-04 | 10.31 |
| 2024-10-03 | 10.35 |